Haemolytic Uraemic Syndrome

Publisher： Karger

E-ISSN： 1660-2110|118|1|c37-c42

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.118, Iss.1, 2010-11, pp. : c37-c42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Escherichia coli 'O' Group Serology of a Haemolytic Uraemic Syndrome (HUS) Epidemic

By Goldwater Paul N.   Bettelheim Karl A.  

Scandinavian Journal of Infectious Diseases, Vol. 32, Iss. 4, 2000-10 ,pp. : 385-394

Informa Healthcare

Access to resources Recommend Favorite

Haemolytic-uraemic Syndrome Caused by Vero Toxin-producing Escherichia coli Serotype Rough: K-: H49

By Keskimäki Markku   Ratiner Yuli   Oinonen Sinikka   Leijala Esko   Nurminen Marjatta   Saari Marjut   Siitonen Anja  

Scandinavian Journal of Infectious Diseases, Vol. 31, Iss. 2, 1999-07 ,pp. : 141-144

Informa Healthcare

Access to resources Recommend Favorite

Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 1, 2015-07 ,pp. : 118-125

John Wiley & Sons Inc

Access to resources Recommend Favorite

Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 2, 2015-08 ,pp. : 306-313

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 10, 2015-10 ,pp. : 1054-1065

John Wiley & Sons Inc

Access to resources Recommend Favorite